Skip to main content
TECON BIOLOGY Co.LTD logo

TECON BIOLOGY Co.LTD — Investor Relations & Filings

Ticker · 002100 ISIN · CNE000001PZ9 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,493 across all filing types
Latest filing 2021-12-23 Major Shareholding Noti…
Country CN China
Listing Shenzhen Stock Exchange 002100

About TECON BIOLOGY Co.LTD

https://www.tcsw.com.cn

TECON BIOLOGY Co.LTD operates an integrated industrial chain focused on animal health and nutrition. The company specializes in the research, development, and manufacturing of veterinary biological products, including a comprehensive range of vaccines and diagnostic reagents for livestock. Its operations encompass the production of high-quality animal feed and the management of large-scale breeding programs, with a primary focus on pig farming and meat processing. By leveraging advanced biotechnology and standardized production systems, the company provides comprehensive solutions for livestock management and food safety. Key activities include the formulation of specialized animal nutrition products and the implementation of rigorous biosecurity protocols across its facilities to ensure the quality and reliability of its agricultural outputs.

Recent filings

Filing Released Lang Actions
关于公司控股股东、实际控制人持股比例被动稀释超过5%暨权益变动的提示性公告
Major Shareholding Notification Classification · 100% confidence The document is a public announcement regarding a change in shareholding proportions due to a non-public stock issuance by the company Tian Kang Biological Co., Ltd. It details the passive dilution of the controlling shareholder's stake by over 5%, with no change in actual control. The document references regulatory approvals and compliance with securities laws and stock exchange rules. It is a notification of a significant shareholding change rather than a full financial report or earnings release. The content fits the definition of a Major Shareholding Notification (MRQ), as it reports a change in significant share ownership levels crossing a threshold (5%). The document length is 2522 characters, which is relatively short and focused on shareholding changes, not a full report or announcement of a report publication. Therefore, the correct classification is MRQ.
2021-12-23 Chinese
简式权益变动报告书（兵团国资公司）
Major Shareholding Notification Classification · 100% confidence The document is titled as a "简式权益变动报告书" which translates to a "Simplified Equity Change Report." It details the change in shareholding percentage of the information disclosure obligor (新疆生产建设兵团国有资产经营有限责任公司) in the listed company 天康生物股份有限公司 due to a non-public issuance of shares by the company. The document includes detailed information about the shareholding before and after the change, the purpose of the change, legal references, and declarations of compliance with disclosure obligations. It is a formal report on a change in major shareholding, specifically describing a passive dilution of shareholding percentage without change in the number of shares held. The document is about a change in significant share ownership levels and complies with regulatory disclosure requirements. It is not an annual report, earnings release, or management report, nor is it a proxy statement or voting result announcement. It fits the definition of a Major Shareholding Notification (MRQ). The document length (5544 characters) and content confirm it is the report itself, not just an announcement of a report publication or a certification. Therefore, the correct classification is MRQ with high confidence.
2021-12-23 Chinese
关于公司持股5%以上股东持股比例被动稀释超过1%的公告
Major Shareholding Notification Classification · 95% confidence The document is an official announcement from Tian Kang Biological Co., Ltd. regarding the passive dilution of shareholding percentages of shareholders holding more than 5% of the company's shares. It details the changes in shareholding proportions due to a non-public issuance of shares, referencing regulatory approval from the China Securities Regulatory Commission. The document includes specific data on shareholding before and after dilution for two major shareholders, explanations of the nature of the changes, and compliance statements. There are no financial statements, earnings data, or management discussion of financial results. The document is a regulatory announcement about changes in major shareholdings due to capital increase and dilution effects, not a full report or financial statement. Therefore, it fits best under the category of Major Shareholding Notification (MRQ). The document length is 3443 characters, which is consistent with a detailed announcement but not a full report.
2021-12-23 Chinese
简式权益变动报告书（天邦鸿康）
Major Shareholding Notification Classification · 100% confidence The document is titled as a "简式权益变动报告书" which translates to a "Simplified Equity Change Report". It details the change in shareholding percentage of an information disclosure obligor (新疆天邦鸿康创业投资有限合伙企业) in the listed company 天康生物股份有限公司 due to a non-public issuance of shares by the company, resulting in passive dilution of the shareholding percentage. The document includes detailed information about the shareholder, the nature of the shareholding change, legal references, and confirms no change in the number of shares held but a decrease in percentage ownership. It also states that the shareholder is no longer a 5% or more shareholder after the dilution. This type of document corresponds to a Major Shareholding Notification (MRQ), which reports changes in significant share ownership levels crossing thresholds. The document is about a shareholding change notification rather than a financial report or other types of filings.
2021-12-23 Chinese
关于天康转债转股价格调整的公告
Capital/Financing Update Classification · 95% confidence The document is an official announcement from Tian Kang Biological Co., Ltd. regarding the adjustment of the conversion price of its convertible bonds (referred to as 'Tian Kang Convertible Bonds'). It details the background of the bond issuance, the regulatory approvals, the formulas for adjusting the conversion price based on corporate actions, and the specific adjustment effective December 24, 2021. The document is a formal notice about a change in the convertible bond's conversion price, not a full financial report or earnings release. It is a regulatory announcement related to capital structure changes, specifically about convertible bond terms. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length is 2293 characters, which is consistent with an announcement rather than a full report.
2021-12-22 Chinese
2021年第四次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled as the "2021 Fourth Extraordinary General Meeting Resolution Announcement" of Tian Kang Biological Co., Ltd. It details the convening of a shareholders' meeting, attendance, voting procedures, and the voting results on specific proposals. It also includes legal opinions on the meeting's validity. The document is an official announcement of the voting results from a shareholders' meeting, not the meeting materials or the full report itself. The length is short (1784 characters), and it primarily reports the voting outcomes and legal validation. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2021-12-22 Chinese

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.